Cargando…

An Update on Adverse Cutaneous Drug Reactions in HIV/AIDS

BACKGROUND: The global mortality from HIV and the cutaneous burden of infective, inflammatory and malignant diseases in the setting of AIDS have significantly declined following the advent of highly active antiretroviral therapy. Regrettably, there has been a contemporaneous escalation in the incide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoosen, Koraisha, Mosam, Anisa, Dlova, Ncoza Cordelia, Grayson, Wayne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827458/ https://www.ncbi.nlm.nih.gov/pubmed/31700852 http://dx.doi.org/10.1159/000496389

Ejemplares similares

Lupus Masquerading as a Drug Reaction in HIV Infection
por: Mosam, Anisa, et al.
Publicado: (2019)

Giant annular lichenoid drug eruption caused by efavirenz therapy
por: Baumrin, Emily, et al.
Publicado: (2018)

The impact of basic dermatology education and training on primary healthcare providers in KwaZulu-Natal, South Africa
por: Makaula, Pumeza U., et al.
Publicado: (2021)

Peri-Umbilical Lymphangioma Circumscriptum Associated with Intra-Abdominal Lymphatic Malformations
por: Singh, Bhavna, et al.
Publicado: (2019)

ADVERSE CUTANEOUS DRUG REACTION
por: Nayak, Surajit, et al.
Publicado: (2008)

Epidemiology of cutaneous adverse drug reactions
por: Mockenhaupt, M.
Publicado: (2017)

Primary Cutaneous Anaplastic Large-Cell Lymphoma
por: Moodley, Nerissa, et al.
Publicado: (2019)

Adverse cutaneous drug reactions
por: Adibi, Neda
Publicado: (2014)

Outcomes of Stevens–Johnson syndrome and toxic epidermal necrolysis in HIV-infected patients when using systemic steroids and/or intravenous immunoglobulins in Pietermaritzburg, South Africa
por: Chateau, Antoinette V., et al.
Publicado: (2019)

Melasma in people with darker skin types: a scoping review protocol on prevalence, treatment options for melasma and impact on quality of life
por: Mpofana, Nomakhosi, et al.
Publicado: (2023)

The Effect of Melasma on the Quality of Life in People with Darker Skin Types Living in Durban, South Africa
por: Mpofana, Nomakhosi, et al.
Publicado: (2023)

Updates in the understanding and treatments of skin & hair disorders in women of color()()
por: Lawson, Christina N., et al.
Publicado: (2015)

Updates in the understanding and treatments of skin & hair disorders in women of color()()()
por: Lawson, Christina N., et al.
Publicado: (2017)

Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions
por: Orime, Mari
Publicado: (2017)

Pericardial, pleural effusion and anasarca: A rare complication of low-dose oral minoxidil for hair loss
por: Dlova, Ncoza C., et al.
Publicado: (2022)

Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies
por: Ng, Chau Yee, et al.
Publicado: (2018)

Cutaneous Adverse Reactions of Amiodarone
por: Jaworski, Krzysztof, et al.
Publicado: (2014)

Recognition of Dual or Multiple Pathology in Skin Biopsies from Patients with HIV/AIDS
por: Grayson, Wayne
Publicado: (2011)

Causality Assessment of Cutaneous Adverse Drug Reactions
por: Son, Young-Min, et al.
Publicado: (2011)

Cutaneous adverse drug reactions induced by Oxcarbazepine
por: Hsiao, Yi-Hsin, et al.
Publicado: (2014)

Unusual and Interesting Adverse Cutaneous Drug Reactions
por: Masatkar, Vaishali, et al.
Publicado: (2018)

Controversies in the Management of Cutaneous Adverse Drug Reactions
por: Manchanda, Yashpal, et al.
Publicado: (2018)

The assessment of severe cutaneous adverse drug reactions
por: Copaescu, Ana M, et al.
Publicado: (2022)

Dermoscopic Aspects of Cutaneous Adverse Drug Reactions
por: Rossi, Gabriela, et al.
Publicado: (2021)

Prevalence of pigmentary disorders: A cross-sectional study in public hospitals in Durban, South Africa()
por: Dlova, Ncoza C., et al.
Publicado: (2019)

En coup de sabre morphea: an uncommon condition in Africa
por: Makhakhe, Lehlohonolo, et al.
Publicado: (2022)

‘It breaks my heart’: Healthcare practitioners’ caring for families with epidermolysis bullosa
por: Chateau, Antoinette V., et al.
Publicado: (2023)

Treatments for Severe Cutaneous Adverse Reactions
por: Cho, Yung-Tsu, et al.
Publicado: (2017)

Associations of HLA genetic variants with carbamazepine‐induced cutaneous adverse drug reactions: An updated meta‐analysis
por: Biswas, Mohitosh, et al.
Publicado: (2022)

Cutaneous Adverse Drug Reactions in Dogs Treated with Antiepileptic Drugs
por: Koch, Tina, et al.
Publicado: (2016)

Vancomycin-Associated Spontaneous Cutaneous Adverse Drug Reactions
por: An, So-Yeon, et al.
Publicado: (2011)

Recent Advances in Severe Cutaneous Adverse Drug Reaction
por: Das, Sudip, et al.
Publicado: (2018)

Genetic markers of severe cutaneous adverse reactions
por: Jung, Jae-Woo, et al.
Publicado: (2018)

Chemokines in Severe Cutaneous Adverse Reactions (SCARs)
por: Miyagawa, Fumi, et al.
Publicado: (2021)

HIV/AIDS: global trends, global funds and delivery bottlenecks
por: Coovadia, Hoosen M, et al.
Publicado: (2005)

Multiple drug hypersensitivity associated with severe cutaneous adverse reaction
por: Lin Choo, Karen Jui, et al.
Publicado: (2014)

Severe Cutaneous Adverse Drug Reactions: A Clinicoepidemiological Study
por: Sasidharanpillai, Sarita, et al.
Publicado: (2015)

Probable cutaneous adverse drug reaction to piroxicam in a cat
por: Young, Amanda J, et al.
Publicado: (2018)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Severe Cutaneous Adverse Reactions Caused by Anti-Tubercular Drugs
por: Kim, Sang-Heon
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vdmje3req8e42ocuicomiosb61